Sign up


Match Document Document Title
7622459 Method of preparation of a fungal glucane hydrogel having antibacterial and immunostimulant activity, and use thereof  
A method of preparation of a fungal glucane hydrogel having antibacterial and immunostimulant activity by alkaline deproteination and subsequent elimination of water-soluble components consists in...
7618951 Use of prebiotics, preferably glucooligosaccharide, for the prevention of the onset of type II diabetes  
The invention relates to the use of prebiotics for the preparation of food or pharmaceutical compositions which are intended for the treatment and/or prevention of hyperglycaemic syndromes and, in...
7612029 Controlled release using gels in a melamine foam  
A substrate comprising a nonwoven layer containing an ionically crosslinked polymer can be used to control the release of active ingredients. The substrate can be a melamine foam and contain a...
7608436 Process for producing saccharide oligomers  
A process for preparing saccharide oligomers uses an aqueous feed composition that comprises at least one monosaccharide or linear saccharide oligomer, and has a solids concentration of at least...
7601704 Process for synthesizing oil and surfactant-free hyaluronic acid nanoparticles and microparticles  
A method for synthesizing uniformly sized hyaluronic acid (“HA”) particles that are substantially free from oil and surfactant contaminants. The method comprises crosslinking HA chains with 1-e...
7601364 Carbohydrate mixtures  
A carbohydrate mixture for dietetic foods and pharmaceuticals containing several carbohydrates is provided. The carbohydrate mixture comprises two different, substantially soluble carbohydrate...
7595307 Polysaccharide derivatives and uses in induction of an immune response  
The present invention generally provides compositions comprising a polysaccharide derivative, and methods of their preparation and use for the prevention or treatment of diseases caused by...
7592327 Asthma/allergy therapy that targets T-lymphocytes and/or eosinophils  
A pharmaceutical composition for the treatment and/or prophylaxis of diseases caused by type I hypersensitivity reactions consisting essentially of Glicophosphopeptical, or pure Nigella Sativa...
7589080 β-cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases  
Methods of reducing the risk of transmission of a sexually transmitted pathogen by contacting the pathogen or cells susceptible to infection by the pathogen with a β-cyclodextrin are provided. ...
7589051 Cationic, oxidized polysaccharides in conditioning applications  
A cationic, oxidized polysaccharide or derivative thereof that has a mean average molecular weight (Mw) having a lower limit of 50,000 and an upper limit of 1,000,000 and an aldehyde functionality...
7582620 Use of mannan from saccharomyces cerevisiae for the treatment of asthma  
The present invention provides methods of using mannose receptor blocker to treat airway disease such as asthma. The present invention also provides methods for reducing smooth muscle mass in an...
7579017 Physical mode of action pesticide  
A physical mode of action pesticide for application on plants and in soils, and methods of manufacture and application, comprising an active ingredient in the form of a polymer in a concentration...
7576070 Method for producing pectin hydrolysis products  
The present invention relates to methods for the production of pectin hydrolysis products, the pectin hydrolysis products produced in this manner, as well as their use.
7576071 Antithrombotic compound  
The present invention relates compounds of the formula A oligosaccharide-spacer-GpIIb/IIIa antagonist (A). The compounds of the invention have antithrombotic activity and can be used in treating or...
7575755 Immunogenic compositions and uses thereof  
The present invention relates generally to a method of eliciting or otherwise inducing an effective immune response to a micro-organism and compositions for use therein. More particularly, the...
7569557 Compositions of estrogen-cyclodextrin complexes  
Pharmaceutical compositions comprising low doses of sensitive complexes between an estrogen and a cyclodextrin are provided with improved stability. In specific embodiments the composition...
7566704 Very high molecular weight β-glucans  
The invention pertains to compositions and therapeutic and prophylatic methods for treating/preventing infections in an animal or human by administering a soluble β-glucan composition comprising ...
7560443 Mixtures of fructose, sucrose and lactose as a low-calorie bulk sweetener with reduced glycemic index  
Mixtures of fructose and lactose are useful for reducing caloric intake and glycemic index for individuals who are overweight, glucose-impaired, diabetic, or who just consume too large a fraction...
7553479 Heat stable colloidal iron oxides coated with reduced carbohydrates and uses thereof  
Compositions, methods of making the compositions, and methods of using the compositions are provided for an enhanced magnetic resonance imaging agent and a hematinic agent, the agents comprising...
7553482 Use of a phosphate adsorbent to combat vascular diseases  
The invention relates to the use of an adsorption material which has been modified with polynuclear metal oxide hydroxides for influencing the calcium level and, in particular, for treating or/and...
7553824 Kit for determining polysaccharide-binding activity of mononuclear cells present in peripheral blood  
A kit for the determination of the ability of a peripheral blood mononuclear cell to bind to a polysaccharide herein provided comprises a detection reagent comprising a fluorescence-labeled...
7544671 Stabilized hyaluronan preparations and related methods  
Stabilized hyaluronan preparations wherein hyaluronan is combined with a polyglycol, such as polyethylene glycol. Stabilized hyaluronan preparations of this invention may maintain their viscosity...
7538096 Treatment and prevention of abnormal cellular proliferation  
This invention provides a method for inhibiting or preventing the abnormal growth of cells, including transformed cells, by administering an effective amount of O-acylated heparin derivative....
7524514 Biomimetic composition reinforced by a polyelectrolytic complex of hyaluronic acid and chitosan  
The present invention relates to a three dimensional, malleable cell culture composition and method of forming the same comprising hyaluronic acid, chitosan and a polyelectrolytic complex of...
7521433 Gene carriers with the use of polysaccharide and process for producing the same  
Disclosed are gene carriers utilizing β-1,3-glucan and methods of preparing the same. The β-1,3-glucan has at least one 1,6-glucopyranoside branch and is chemically modified through periodate o...
7521434 Cross-linked gels of hyaluronic acid with hydrophobic polymers and processes for making them  
The present invention provides for compositions of hyaluronic acid cross-linked with at least one other hydrophobic polymer to form a copolymer gel. The preferred composition is a formulation...
7514097 Use of soluble cellulose derivative having been made hardly soluble in water and process for producing the same  
(1) A tissue-covering medical material which comprises a soluble cellulose derivative having been made hardly soluble in water, which is used with a purpose of being embedded in the body or applied...
7511026 Therapeutic agent for nerve damage  
The present invention provides a therapeutic agent for nerve damages such as those caused by spinal cord injury or nerve trauma, which includes, as an active ingredient, a low-molecular-weight...
7511095 Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith  
The invention provides reagents and methods for conjugating a polymer specifically to the α-amine of a polypeptide. The invention provides monofunctional, bifunctional, and multifunctional PEGs ...
7507723 Hyaluronic acid oligosaccharide fractions and drugs containing the same  
Hyaluronic acid oligosaccharides having a size selected from sizes of 4 to 60 saccharides, fractions containing the hyaluronic acid oligosaccharides and having particular physicochemical...
7504384 Use of lipid conjugates in the treatment of infection  
This invention provides compounds and methods of use thereof in suppressing, inhibiting, preventing, or treating a pathogenic effect on a cell, including, inter alia, infection with intracellular...
7504386 Biomaterials for preventing post-surgical adhesions comprised of hyaluronic acid derivatives  
New biomaterials essentially constituted by esterified derivatives of hyaluronic acid or by cross-linked derivatives of hyaluronic acid for use in the surgical sector, particularly for use in the...
7504387 Glycosaminoglycan composition and method for treatment and prevention of interstitial cystitis  
The invention provides compositions and methods useful for the treatment and/or prevention of interstitial cystitis and/or a related urinary tract condition in man or in animals. Specifically,...
7501402 Fucose containing proteoglycan or acidic glycan and their pharmaceutical use  
A class of proteoglycans containing fucosylated acidic glycans, e.g., as produced by marine sponges and sea urchin embryos, have been found to stimulate selective proliferation of mammalian natural...
7498317 Antibacterial agents and process for producing the same  
An antibacterial agent showing a high affinity for Helicobactor pyroli and having an antibacterial effect specific to H. Pyroli. The agent has a chemical structure wherein an antibacterial...
7494674 Nutraceutical with tart cherries and method of treatment therewith  
The present disclosure provides a nutraceutical for the use of a vacuolar flavonoid pigment from a natural source such as tart cherries as an additional compound as part of a mixture including at...
7495030 (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents  
(5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid, salts thereof, and compositions containing the same for the delivery of active agents are provided. Methods of administration, treatment of disease...
7491709 Treatment with hyaluronic acid  
The present invention relates, generally, to methods of providing long-term minimization of wrinkles or folds in the skin by injecting a bolus of hyaluronic acid deep into the skin. The methods of...
7491708 Modified pectin  
A modified pectin consists essentially of neutral sugar sequences with a low degree of branching capable of preventing tumor cell migration and cell to cell and cell to substratum adhesion.
7482026 Compositions and methods directed towards sore muscles and joints  
Chemical formulations and methods for reducing muscle and joint soreness are disclosed. A representative chemical formulation includes compounds such as a selenium-compound, chondroitin sulfate,...
7473429 Method for treatment of laminitis in animals  
The present invention generally relates to methods for treating the sequela of laminitis in hoofed animals. Benefits are obtained by administering to the animals to be treated injections of...
7465716 Targeted drug delivery with a hyaluronan ligand  
The invention is a drug delivery system of a delivery vehicle having a low molecular weight hyaluronan ligand with an affinity for CD44 receptors. Preferably, the delivery vehicle is a liposome but...
7462606 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring  
The present invention relates to hyaluronic acid ester derivatives, whose carboxylic groups are partially esterified with hydroxyl groups of propiophenone derivatives, to the hydrogel materials...
7462607 Therapy-enhancing glucan  
This invention provides a composition comprising an effective amount of (1-3),(1-4)-β-glucan derived from barley capable of enhancing efficacy of antibodies. This invention further provides the ...
7462369 Anti-viral compositions and methods of making and using the anti-viral compositions  
Disclosed are anti-viral compositions containing at least one zinc compound and at least one phenolic antioxidant (and optionally other ingredients), and a pharmaceutical carrier. Also disclosed...
7462702 ***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***
High molecular weight, low methoxyl pectins, and their production and uses
 
Pectins having a combination of unexpectedly high molecular weights and low degrees of methylation have been isolated. These high molecular weight, low degree of methylation pectins form gels at...
7459150 Heat activated durable conditioning compositions comprising an aminated C5 to C7 saccharide unit and methods for using same  
Compositions, optionally heat activated, methods, and kits for caring for, treating or durable conditioning of at least one keratinous fiber comprising at least one compound comprising at least two...
7449452 Method for estimating immunostimulant activity of a polysaccharide  
The ability of a polysaccharide to act as an immunostimulant may be assessed by comparing the degree of binding of a detection reagent, which contains a fluorescence-labeled version of the...
7449448 Composition and uses therefor for combating hangovers  
The present invention relates generally to a composition for use in the prophylaxis and/or treatment of one or more symptoms caused or exacerbated by consumption of alcohol which composition...
7446131 Porous polymeric matrices made of natural polymers and synthetic polymers and optionally at least one cation and methods of making  
A porous polymeric matrix containing at least one natural polymer and at least one synthetic polymer and optionally at least one cation. Furthermore, a method of making a porous polymeric matrix...